2019
DOI: 10.1164/rccm.201809-1651oc
|View full text |Cite
|
Sign up to set email alerts
|

Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

8
53
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 80 publications
(63 citation statements)
references
References 23 publications
8
53
0
1
Order By: Relevance
“…Exacerbations in bronchiectasis can be caused by a range of bacteria, viruses and environmental factors; making it hard to determine the role of the microbiome in exacerbations [51]. It is known from culture studies that bacterial load is important in lung inflammation and treatment response [14,52]. Microbiome changes during exacerbation are heterogeneous.…”
Section: Does the Microbiome Play A Role In Exacerbations And Affect mentioning
confidence: 99%
“…Exacerbations in bronchiectasis can be caused by a range of bacteria, viruses and environmental factors; making it hard to determine the role of the microbiome in exacerbations [51]. It is known from culture studies that bacterial load is important in lung inflammation and treatment response [14,52]. Microbiome changes during exacerbation are heterogeneous.…”
Section: Does the Microbiome Play A Role In Exacerbations And Affect mentioning
confidence: 99%
“…The authors studied a large cohort of patients with IPF who underwent both research bronchoscopy and quantitative interpretations of chest computed tomography (CT) scans. To characterise lung bacteria, the authors quantified total lung bacterial DNA burden, which has been the most consistent microbial predictor of clinical outcomes across respiratory conditions [11,13,20,21]. In their analysis of CT imaging, they quantified the severity and extent of fibrosis, including key features such as traction bronchiectasis and honeycombing.…”
mentioning
confidence: 99%
“…33–41) have undertaken a post hoc analysis of two negative trials in patients with non–cystic fibrosis bronchiectasis (8) and generated important messages for clinicians, scientists, and the pharmaceutical industry. The data confirm a relationship between routine quantitative microbiology with a bacterial load of 10 7 cfu and neutrophilic inflammation as reflected by the green color of myeloperoxidase.…”
mentioning
confidence: 99%